Dr Landon MottProcess Development Principal Scientist at Amgen Inc.Speaker
Profile
Landon joined Amgen in 2019 where he now leads a team of upstream and downstream process development scientists to advance next generation modalities through a challenging development landscape. His team’s automation and modelling expertise has enabled timeline savings for early-phase cell line dev, upstream cell culture, as well as purification process development activities.
Agenda Sessions
End-to-End Automation Solutions: Doing More with Less to Accelerate Timelines in FIH Clone Screening
, 9:00amView Session